New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
about
Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report.EGFR L861Q Mutation in a Metastatic Solid-pseudopapillary Neoplasm of the Pancreas.
P2860
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@ast
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@en
type
label
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@ast
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@en
prefLabel
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@ast
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@en
P2093
P2860
P1476
New data on clinical decisions in NSCLC patients with uncommon EGFR mutations.
@en
P2093
Chia-Chi Lin
Jih-Hsiang Lee
Ting-Hui Wu
P2860
P356
10.1080/17476348.2017.1267569
P577
2016-12-07T00:00:00Z